Tags

Type your tag names separated by a space and hit enter

Immunisation with a pneumococcal 7-valent conjugate vaccine.
Int J Clin Pract. 2002 May; 56(4):287-91.IJ

Abstract

Pneumococcal disease causes approximately 1 million deaths a year worldwide in children aged younger than 5 years. Increasing antibiotic-resistant strains have made management of pneumococcal disease difficult. A pneumococcal 7-valent conjugate vaccine (PNCRM7) has been shown to prevent invasive disease in young children; it has also demonstrated a modest impact on the prevention of otitis media. This conjugated vaccine provides a consistent immune response in infants and young children and can be administered simultaneously with other childhood vaccines. It is generally well tolerated, with local reactions similar to those observed with other licensed childhood vaccines. The objective of this review is to discuss the clinical efficacy, immunogenicity and safety of PNCRM7.

Authors+Show Affiliations

Paediatric Infectious Disease Unit, Soroka University Medical Centre, Beer-Sheva, Israel.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

12074212

Citation

Dagan, R. "Immunisation With a Pneumococcal 7-valent Conjugate Vaccine." International Journal of Clinical Practice, vol. 56, no. 4, 2002, pp. 287-91.
Dagan R. Immunisation with a pneumococcal 7-valent conjugate vaccine. Int J Clin Pract. 2002;56(4):287-91.
Dagan, R. (2002). Immunisation with a pneumococcal 7-valent conjugate vaccine. International Journal of Clinical Practice, 56(4), 287-91.
Dagan R. Immunisation With a Pneumococcal 7-valent Conjugate Vaccine. Int J Clin Pract. 2002;56(4):287-91. PubMed PMID: 12074212.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Immunisation with a pneumococcal 7-valent conjugate vaccine. A1 - Dagan,R, PY - 2002/6/21/pubmed PY - 2002/7/18/medline PY - 2002/6/21/entrez SP - 287 EP - 91 JF - International journal of clinical practice JO - Int J Clin Pract VL - 56 IS - 4 N2 - Pneumococcal disease causes approximately 1 million deaths a year worldwide in children aged younger than 5 years. Increasing antibiotic-resistant strains have made management of pneumococcal disease difficult. A pneumococcal 7-valent conjugate vaccine (PNCRM7) has been shown to prevent invasive disease in young children; it has also demonstrated a modest impact on the prevention of otitis media. This conjugated vaccine provides a consistent immune response in infants and young children and can be administered simultaneously with other childhood vaccines. It is generally well tolerated, with local reactions similar to those observed with other licensed childhood vaccines. The objective of this review is to discuss the clinical efficacy, immunogenicity and safety of PNCRM7. SN - 1368-5031 UR - https://www.unboundmedicine.com/medline/citation/12074212/Immunisation_with_a_pneumococcal_7_valent_conjugate_vaccine_ L2 - https://medlineplus.gov/pneumococcalinfections.html DB - PRIME DP - Unbound Medicine ER -